Avaleht › Müeloom › New Jersey › Edison
Müeloom kliinilised uuringud linnas Edison, NJ
22 uuringut haiguse Müeloom jaoks otsivad osalejaid linnas Edison ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
VärbamineFaas 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi kaugusel
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
VärbamineFaas 3
- Astera Cancer Care, East Brunswick · 6 mi kaugusel
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
VärbamineFaas 3
- Astera Cancer Care, East Brunswick · 6 mi kaugusel
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
VärbamineFaas 3
- MSK Basking Ridge, Basking Ridge · 15 mi kaugusel
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
VärbamineFaas 4
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi kaugusel
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
VärbamineFaas 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi kaugusel
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
VärbamineFaas 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi kaugusel
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
VärbamineFaas 3
- MSK Basking Ridge, Basking Ridge · 15 mi kaugusel
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
VärbamineFaas 1
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi kaugusel
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
VärbamineFaas 3
- Research Site, East Brunswick · 6 mi kaugusel
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
VärbamineVaatlusuuring
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi kaugusel
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
VärbamineFaas 1/2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi kaugusel
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
VärbamineFaas 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi kaugusel
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
VärbamineFaas 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi kaugusel
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
VärbamineVarajane 1. faas
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi kaugusel
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Brunswick · 3 mi kaugusel
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
VärbamineFaas 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi kaugusel
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
VärbamineFaas 1
- Rutgers Cancer Institute of New Jersey /ID# 266833, New Brunswick · 3 mi kaugusel
A Dietary Study for People With Multiple Myeloma
Värbamine
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi kaugusel
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
VärbamineFaas 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi kaugusel
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
VärbamineFaas 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi kaugusel
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi kaugusel
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Värbamine
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi kaugusel
Müeloom uuringud teistes linnades
- New York City, NY60 uuringut
- Boston, MA42 uuringut
- Atlanta, GA41 uuringut
- Houston, TX38 uuringut
- Durham, NC37 uuringut
- Nashville, TN32 uuringut
- Denver, CO27 uuringut
- Rochester, MN24 uuringut
- St. Louis, MO24 uuringut
- Columbus, OH24 uuringut
- Baldwin Park, CA23 uuringut
- Chicago, IL22 uuringut
Muud uuringud linnas Edison
- Rinnavähk68 uuringut
- Mitteväikerakuline kopsuvähk47 uuringut
- Vähk (kõik liigid)33 uuringut
- Eesnäärmevähk29 uuringut
- Käär- ja pärasoolevähk23 uuringut
- Kopsuvähk23 uuringut
- Põievähk21 uuringut
- Metastaatiline vähk20 uuringut
- Munasarjavähk20 uuringut
- Äge müeloidne leukeemia20 uuringut
- Endomeetriumivähk19 uuringut
- Uroteeliaalne (ülemineku-rakkude) kartsinoom18 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.